Veklury was the first drug to get full FDA approval for COVID-19
Consistently, GSH application on leaf 1 significantly induced the expression of defense-responsive genes ( OPR3 , JAZ5 , and JAZ10 ) in leaf 6 (by ~5.6, ~8.6 and ~5.7 folds), which is comparable to that induced by Glu (Fig
Yet BPC-157, short for Body Protection Compound-157, has accumulated a striking body of preclinical evidence suggesting it accelerates tendon healing, repairs intestinal injury, modulates the nervous system, and does so without the toxicity profile that complicates many pharmacological interventions
In the past, FDA has declined to add these substances to the bulk compounding list because of safety and/or efficacy concerns
Reconstitute with bacteriostatic water for research handling